Important research, explained clearly for patients and families.
Each update will describe the research question, key findings, who the evidence may apply to, and its limitations.
An 11-study review involving 3,611 patients found similar rates of major complications with shorter and conventional schedules.
Read the summary ↗
A 1,094-patient study explores recurrence risk when cervical lymph nodes are cancer-free on pathology.
Read the summary ↗
Forty-nine consensus statements aim to improve how symptoms, imaging and treatment outcomes are measured in research.
Read the summary ↗
MASCC guidance based on 19 clinical trials explains when prescribed steroid creams may help selected patients.
Read the summary ↗
A 1,175-patient study offers a model to estimate recurrence risk and support individualized treatment discussions.
Read the summary ↗
A 2026 international review explains how DIBH can help reduce the radiation dose to the heart.
Read the summary ↗What clinical uncertainty did the researchers investigate?
What was observed, without exaggerating the conclusions.
Who may find the results relevant, and whether they are ready to change care.
Important limitations, uncertainties and context.
These summaries are educational, not personalised treatment recommendations.